BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 25048396)

  • 1. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
    Wong CC; Tse AP; Huang YP; Zhu YT; Chiu DK; Lai RK; Au SL; Kai AK; Lee JM; Wei LL; Tsang FH; Lo RC; Shi J; Zheng YP; Wong CM; Ng IO
    Hepatology; 2014 Nov; 60(5):1645-58. PubMed ID: 25048396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
    Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism.
    Wu S; Xing X; Wang Y; Zhang X; Li M; Wang M; Wang Z; Chen J; Gao D; Zhao Y; Chen R; Ren Z; Zhang K; Cui J
    Eur J Cancer; 2021 Apr; 147():63-73. PubMed ID: 33618200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
    Wu S; Zheng Q; Xing X; Dong Y; Wang Y; You Y; Chen R; Hu C; Chen J; Gao D; Zhao Y; Wang Z; Xue T; Ren Z; Cui J
    J Exp Clin Cancer Res; 2018 May; 37(1):99. PubMed ID: 29728125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
    Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
    Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
    Kai AK; Chan LK; Lo RC; Lee JM; Wong CC; Wong JC; Ng IO
    Hepatology; 2016 Aug; 64(2):473-87. PubMed ID: 27018975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
    Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
    Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.
    Choi J; Chung T; Rhee H; Kim YJ; Jeon Y; Yoo JE; Noh S; Han DH; Park YN
    Gut Liver; 2019 Jan; 13(1):83-92. PubMed ID: 29938458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling.
    Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J
    J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
    Shao B; Zhao X; Liu T; Zhang Y; Sun R; Dong X; Liu F; Zhao N; Zhang D; Wu L; Wang Y; Wang M; Meng J; Lin X; Sun B
    J Cell Mol Med; 2019 Feb; 23(2):1363-1374. PubMed ID: 30506621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma.
    Maroni P; Matteucci E; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
    Breast Cancer Res Treat; 2011 Sep; 129(2):433-50. PubMed ID: 21069452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma.
    Xu J; Li D; Li X; Liu Z; Li T; Jiang P; He Q; Tian F; Gao Y; Wang D; Wang S
    Dig Liver Dis; 2014 Aug; 46(8):750-7. PubMed ID: 24794791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer.
    Zhu G; Wang L; Meng W; Lu S; Cao B; Liang X; He C; Hao Y; Du X; Wang X; Li L; Li L
    Theranostics; 2021; 11(19):9198-9216. PubMed ID: 34646366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2.
    Chen X; Kou Y; Lu Y; Pu Y
    J Cell Biochem; 2020 Jan; 121(1):165-173. PubMed ID: 31162697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells.
    Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q
    Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix stiffness-mediated effects on macrophages polarization and their LOXL2 expression.
    Xing X; Wang Y; Zhang X; Gao X; Li M; Wu S; Zhao Y; Chen J; Gao D; Chen R; Ren Z; Zhang K; Cui J
    FEBS J; 2021 Jun; 288(11):3465-3477. PubMed ID: 32964626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.